Overview About 10 Leaps Collaboration Impact

Overview Leaps Talks Chapter Films Leaps.org Partners

Agriculture Health

Overview Annual Review Breakthrough Study Press Releases In the News Reports Leaps Leadership Press Kit Media Contact

Approach
Engagement
- Agriculture
- Health
News
Team

Contact Imprint Privacy Statement Conditions of Use

sign up for our newsletter

Our return to humanity

The Leaps team brings together a diverse group of individuals with expertise in biotech, healthcare, agriculture, investment, and communication.

Explore Our Team

Press coverage of Leaps and portfolio companies

Year

Category

02-13-2024
Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M
Read
01-06-2024
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Read
11-09-2023
Bayer and Recursion focus research collaboration on Oncology
Read
10-05-2023
65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Singapore
Read
08-29-2023
Gene Editing: Pairwise and Bayer start new five-year multi-million Dollar collaboration to further advance short-stature corn
Read
05-16-2023
Boundless Bio Announces $100 Million Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance First ecDNA-Directed Therapies for Patients with Oncogene Amplified Cancer
Read
05-10-2023
ChrysaLabs Secures CA $15 Million ($11 Million) Series A Funding to Increase Instant Access to Reliable and Low-Cost Soil Insights, Including Carbon Verification
Read
02-27-2023
What can bats, naked mole rats and Jaws tell us about human biology? Paratus is on a $100M mission to find out
Read
01-19-2023
Bayer launches new collaboration with Oerth Bio to further advance innovations in crop protection
Read
01-10-2023
NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs
Read
01-09-2023
AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform
Read
11-03-2022
Leaps by Bayer leads investment round in AgTech pioneer NuCicer to bring unique and cost-effective plant-protein ingredients to market by 2023
Read
09-14-2022
Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering
Read
08-01-2022
Bayer expands existing investment to acquire majority share in sustainable lower carbon oilseed producer CoverCress Inc.
Read
06-29-2022
ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M
Read
03-22-2022
Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations
Read
03-15-2022
Woebot Health Secures $9.5 Million Investment From Leaps by Bayer
Read
02-10-2022
Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer
Read
01-31-2022
Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions
Read
01-25-2022
Leaps by Bayer leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing
Read
12-09-2021
Bloom Science Raises USD $12 Million in Series A Financing
Read
11-21-2021
Immunitas Therapeutics Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform
Read
11-16-2021
Deka Biosciences Raises USD 20 Million in Series A Financing
Read
11-03-2021
GRO Biosciences Announces $25M Series A Financing Led by Leaps by Bayer and Redmile Group
Read
10-26-2021
Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases
Read
09-21-2021
EarthOptics Raises $10.3 million in Series A Funding, Led by Leaps by Bayer, to Accelerate Carbon Mapping
Read
08-01-2021
Leaps by Bayer Leads USD 45 Million Financing in Sound Agriculture to Accelerate Sustainability Solutions for Food and Agriculture
Read
06-09-2021
Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology
Read
05-27-2021
Leaps by Bayer leads USD 90 Million Series B financing in digital health company Ada Health
Read
04-22-2021
Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging
Read
04-06-2021
Guardian Agriculture Launches With $10.5 Million Financing to Modernize Crop Protection With eVTOL-Powered Precision
Read
03-23-2021
Amfora Raises $6 Million with Investment from Leaps by Bayer and Spruce Capital Partners
Read
01-27-2021
Ukko secures USD 40 million in Series B funding led by Leaps by Bayer to overcome food allergies and sensitivities
Read
01-06-2021
Leaps by Bayer leads Series B financing in Senti Bio to develop next-generation cell and gene therapies using advanced gene circuit technology platform
Read
12-02-2020
Bayer backs drone spraying platform Rantizo in $7.5m Series A round
Read
11-12-2020
Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund
Read
10-15-2020
Leaps by Bayer leads USD 17 million Series B financing in biotech company Azitra
Read
09-09-2020
Bayer collaborates with Recursion to strengthen efforts in digital drug discovery and advance new therapies for fibrotic diseases.
Read

back to press releases